Posted in | News | Gold

Robex Resources Announces Trenching Program at Moussala Permit

Robex Resources announced a trenching exploration program at the Moussala permit, Southwest Mali. The exploration work at this permit will include mining of three trenches of length 100 m and depth of over 3 m, along with the completion of regolith mapping. The company has 100% rights in the permit.

The Moussala permit is situated in the southern part of Kenieba’s gold-bearing province, which is approximately 30 km towards the southern part of the Tabakoto and Loulo mine. This permit has enclosed an area of 67 sq. km. It is connected with the early Proterozoic Birimian sediment that has revealed greenschist facies metaphorphism. The structures are cut across by the igneous rock with a composition of mafic and felsic. The claim has extensive structural, geological and geochemical anomalies. The Kenieba area has been exposed to rigorous gold washing that includes Bilali Santo, which is a portion of the similar geological formation as Moussala.

Geochemical surveys showed the presence of eight anomalies during 1997 and 1998. During 2007, Robex conducted a linear trenching program of 777 m at the five anomalies. The results validated the potential of gold-mining at the permit. The three anomalies remaining are situated in the southeast and east portions, and are the program’s target.

The company will mine the trenches till saprolite is reached, wherein the samples will be tested to find if the anomalies continue towards depth. It will plan for the reverse circulation (RC) program, based on the drilling results, and will explore the potential of the depth.

Source: http://www.robexgold.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robex Resources Inc.. (2019, February 18). Robex Resources Announces Trenching Program at Moussala Permit. AZoMining. Retrieved on April 27, 2024 from https://www.azomining.com/News.aspx?newsID=5668.

  • MLA

    Robex Resources Inc.. "Robex Resources Announces Trenching Program at Moussala Permit". AZoMining. 27 April 2024. <https://www.azomining.com/News.aspx?newsID=5668>.

  • Chicago

    Robex Resources Inc.. "Robex Resources Announces Trenching Program at Moussala Permit". AZoMining. https://www.azomining.com/News.aspx?newsID=5668. (accessed April 27, 2024).

  • Harvard

    Robex Resources Inc.. 2019. Robex Resources Announces Trenching Program at Moussala Permit. AZoMining, viewed 27 April 2024, https://www.azomining.com/News.aspx?newsID=5668.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.